Safety and Clinical Activity of Itolizumab in aGVHD

Clinical trial NCT05823675 · UNKNOWN

Trial details

NCT number: NCT05823675
Sponsor: Biotech Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Graft Versus Host Disease

Start date: 2023-05-19
Primary completion: 2024-10-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.